Stock Analysis

Insider Spends UK£52k Buying More Shares In Advanced Medical Solutions Group

AIM:AMS
Source: Shutterstock

Whilst it may not be a huge deal, we thought it was good to see that the Advanced Medical Solutions Group plc (LON:AMS) CFO & Executive Director, Edward Johnson, recently bought UK£52k worth of stock, for UK£1.92 per share. While we're hesitant to get too excited about a purchase of that size, we do note it increased their holding by a solid 22%.

Check out our latest analysis for Advanced Medical Solutions Group

The Last 12 Months Of Insider Transactions At Advanced Medical Solutions Group

The Independent Non-Executive Chairman Elizabeth Shanahan made the biggest insider purchase in the last 12 months. That single transaction was for UK£100k worth of shares at a price of UK£1.99 each. That means that an insider was happy to buy shares at above the current price of UK£1.89. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. To us, it's very important to consider the price insiders pay for shares. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels.

In the last twelve months insiders purchased 188.97k shares for UK£381k. On the other hand they divested 44.10k shares, for UK£99k. Overall, Advanced Medical Solutions Group insiders were net buyers during the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
AIM:AMS Insider Trading Volume March 21st 2024

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Insider Ownership

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. From our data, it seems that Advanced Medical Solutions Group insiders own 1.0% of the company, worth about UK£3.9m. Whilst better than nothing, we're not overly impressed by these holdings.

So What Do The Advanced Medical Solutions Group Insider Transactions Indicate?

It is good to see recent purchasing. And the longer term insider transactions also give us confidence. We would certainly prefer see higher levels of insider ownership but analysis of the insider transactions suggests that Advanced Medical Solutions Group insiders are expecting a bright future. Therefore, you should definitely take a look at this FREE report showing analyst forecasts for Advanced Medical Solutions Group.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Valuation is complex, but we're helping make it simple.

Find out whether Advanced Medical Solutions Group is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.